에 대한 최신 뉴스 Personalis (NASDAQ:PSNL) 주식

Personalis

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Equities

News

Specialty ETFs

Trading Ideas

ETFs

ARKK

ARKQ

ARKW

BLDE

DKNG

PSNL

TSLA

테슬라(NASDAQ:TSLA)의 주가는 잠재적으로 암울한 분기에 대한 우려와 제품 파이프라인 계획의 전략적 변화에 대한 소문으로 인해 화요일 3일 연속 하락 마감했다. 이러한 곤경에도 불구하고 테슬라 강세를 주장하는 캐시 우드(Cathie Wood)가 운영하는 아크 인베스트(Ark Invest)는 이 주식을 매수했다.

캐시 우드의 아크는 테슬라가 3일 연속 하락하는 동안 330만 달러의 주식 매수

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

ARKF

DDOG

PINS

TWLO

VERV

수요일, Cathie Wood의 Ark Invest가 Pinterest Inc (NYSE:PINS)의 추가 주식을 구매하는 것으로 눈에 띄는 움직임을 보였다.



핀터레스트의 거래



Ark Invest의 Fintech Innovation ETF(NYSE:ARKF)는 인스타그램과 X 플랫폼을 소유한 메타 플랫폼의 경쟁사인 인기 있는 소셜 미디어 웹사이트인 Pinterest 26,925주의

캐시 우드의 아크 인베스트는 메타 플랫폼 경쟁사의 주식을 추가 매입

Personalis Inc

Politics

General

2024 Presidential Election Polls Close In The Following States: GA, IN, KY, SC, VA, VT

Seaport Global analyst Tom Curran initiates coverage on First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Neutral rating.

Initiation

Analyst Ratings

FSLR

Seaport Global Initiates Coverage On First Solar with Neutral Rating

Scotiabank analyst Greg Harrison maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Sector Perform and raises the price target from $480 to $486.

Price Target

VRTX

Scotiabank Maintains Sector Perform on Vertex Pharmaceuticals, Raises Price Target to $486

Scotiabank analyst Greg Harrison maintains Disc Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) with a Sector Outperform and raises the price target from $62 to $70.

IRON

Scotiabank Maintains Sector Outperform on Disc Medicine, Raises Price Target to $70

Scotiabank analyst Mario Saric maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Sector Outperform and raises the price target from $55.5 to $59.5.

Scotiabank Maintains Sector Outperform on Brookfield Asset Mgmt, Raises Price Target to $59.5

Scotiabank analyst Andres Coello maintains TIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIMB#NYSE">TIMB</a>) with a Sector Outperform and lowers the price target from $24.8 to $23.2.

TIMB

Scotiabank Maintains Sector Outperform on TIM, Lowers Price Target to $23.2

Scotiabank analyst Maher Yaghi maintains BCE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BCE#TSX">BCE</a>) with a Sector Perform and lowers the price target from C$50.5 to C$47.5.

TSX:BCE

Scotiabank Maintains Sector Perform on BCE, Lowers Price Target to C$47.5

Citigroup analyst Christopher Danely maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Neutral and lowers the price target from $45 to $40.

Citigroup Maintains Neutral on GLOBALFOUNDRIES, Lowers Price Target to $40

NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) passed Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) to become the world's largest publicly traded <a href="https://www.benzinga.com/news/24/11/41751557/nvidia-takes-short-lived-lead-over-apple-in-valuation">company on Tuesday. </a>
The Details: Nvidia ended Tuesday's trading session with a market capitalization of $3.43 trillion, slightly <a href="https://www.benzinga.com/news/24/11/41751557/nvidia-takes-short-lived-lead-over-apple-in-valuation">edging out </a>Apple&#8217;s $3.38 trillion valuation, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. The semiconductor giant's dominance in the artificial intelligence chip market has fueled its exponential growth of more than 200% over the past year.&nbsp;
Read More: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/11/41724410/nvidia-joining-dow-jones-industrial-average-where-tech-giant-ranks-in-the-index-why-sh">Nvidia Joining Dow Jones Industrial Average: Where Tech Giant Ranks In The Index, Why Sherwin-Williams Addition Could Be More Important</a>
Nvidia briefly passed Apple <a href="https://www.benzinga.com/news/24/06/39386946/microsoft-apple-step-aside-nvidia-is-now-the-most-valuable-public-company-in-the-world">in market cap </a>in June before sliding over the summer.<a href="https://www.cnbc.com/quotes/MSFT/"> </a>Nvidia&#8217;s ascent to the top highlights the growing importance of AI technology and the pivotal role that Nvidia's specialized hardware plays in its development.&nbsp;
Despite Nvidia's remarkable growth over the past year, analysts remain bullish on the company's growth ahead. The three most recent analyst ratings were released by BofA Securities, Goldman Sachs and Morgan Stanley in October with an average price target of $163.33 between the three. There&#8217;s an implied 17.04% upside for Nvidia stock from these analyst ratings.
Last Friday, S&amp;P Dow Jones announced that Nvidia <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/11/41724410/nvidia-joining-dow-jones-industrial-average-where-tech-giant-ranks-in-the-index-why-sh">is joining the Dow Jones Industrial Average on Nov. 8 </a>replacing Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and joining Apple in the blue-chip index. 
NVDA Price Action: According to data from Benzinga Pro, Nvidia shares ended Tuesday's session 2.84% higher at $139.91.&nbsp;
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41690154/shock-october-jobs-report-leaves-fed-in-tight-spot-experts-say-interest-rate-cuts-a">Shock October Jobs Report Leaves Fed In &#8216;Tight Spot:&#8217; Experts Say Interest Rate Cuts Ahead</a></li>
</ul>
Image: Shutterstock

Large Cap

Movers

Tech

AAPL

INTC

NVDA

Nvidia Blows Past Apple To Become World's Most Valuable Company

Lake Street analyst Mark Argento maintains Gaia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAIA#NASDAQ">GAIA</a>) with a Buy and raises the price target from $6 to $7.

GAIA

Lake Street Maintains Buy on Gaia, Raises Price Target to $7

Lake Street analyst Thomas Flaten maintains Castle Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) with a Buy and raises the price target from $34 to $40.

CSTL

Lake Street Maintains Buy on Castle Biosciences, Raises Price Target to $40

Lake Street analyst Jaeson Schmidt maintains NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) with a Buy and lowers the price target from $60 to $41.

NSSC

Lake Street Maintains Buy on NAPCO Security Techs, Lowers Price Target to $41

Gulf Island Fabrication (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIFI#NASDAQ">GIFI</a>) .

Guidance

GIFI

Gulf Island Fabrication expect FY2024 adjusted consolidated EBITDA of $11M-$13M.

Lake Street analyst Eric Martinuzzi maintains QuinStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) with a Hold and raises the price target from $20 to $25.

QNST

Lake Street Maintains Hold on QuinStreet, Raises Price Target to $25

Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) .

SNDX

Syndax Pharmaceuticals FY2024 R&D expenses forecast: $245M-$250M.

Loop Capital analyst Rob Sanderson maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Buy and raises the price target from $14 to $16.

SNAP

Loop Capital Maintains Buy on Snap, Raises Price Target to $16

Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) .

GPOR

Gulfport Energy Full Year 2024: Drilling and completion capex guidance cut to $325M-$335M.

Loop Capital analyst Garik Shmois maintains Knife River Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNF#NYSE">KNF</a>) with a Buy and lowers the price target from $105 to $100.

Loop Capital Maintains Buy on Knife River Holding, Lowers Price Target to $100

Barclays analyst Blayne Curtis maintains NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) with a Overweight and lowers the price target from $330 to $280.

NXPI

Barclays Maintains Overweight on NXP Semiconductors, Lowers Price Target to $280

It's Election day! Voters are visiting polling locations and social media mavens are sharing opinions and local reports in megathreads, polls and comments on Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>).
Here are some notable threads to follow for election <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41631795/reddit-remains-a-favorite-for-wall-street-after-emphatic-beat-and-raise-in-q3">coverage on Reddit.&nbsp;</a>
Polls Open: Subreddit r/politics has over 8.5 million subscribers and features a <a href="https://www.reddit.com/r/politics/comments/1gkefi6/rpolitics_2024_us_elections_live_thread_part_59/">live thread</a> with 59 parts titled, "2024 US Elections Live Thread, Part 59" which contains more than 3,200 comments, voter turnout reports from different locations and live commentary on election developments.&nbsp;
Subreddit r/moderatepolitics has 295,000 members and a <a href="https://www.reddit.com/r/moderatepolitics/">poll titled</a> "Who are you voting for in the 2024 US Presidential Election." At the time of publication, 2,100 Redditors selected Harris, 1,300 selected Trump, 301 selected Other and 842 responded with Not Voting.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/earnings/24/10/41612293/reddit-stock-soars-after-strong-q3-results-q4-guidance-above-estimates-dauqs-grow-17-and-more">Reddit Stock Soars After Strong Q3 Results, Q4 Guidance Above Estimates: DAUq&#8217;s Grow 17% And More</a>
Reddit also features local subreddits like r/Pennsylvania, which has <a href="https://www.reddit.com/r/Pennsylvania/comments/1gjutyd/the_election_day_mega_thread/">a thread</a> titled, "The Election Day Mega Thread" where users can find coverage of the crucial swing state and voting guides and polling locations. The thread also provides local polling updates and news with first-hand accounts from voters across the state.&nbsp;
Where To Find Results: FiveThirtyEight, the data journalism outlet, will feature county-by-county data breakdowns as the polling results come in at its r/fivethirtyeight <a href="https://www.reddit.com/r/fivethirtyeight/">subreddit</a>. It also features discussions about polling accuracy and several live election megathreads.&nbsp;&nbsp;
The r/Journalism <a href="https://www.reddit.com/r/Journalism/">subreddit</a> will provide authoritative sources for results, including updates from the Associated Press and major networks, as well as discussions about result reporting methodology.&nbsp;
Reddit&#8217;s election coverage offers a blend of real-time updates and community engagement across various specialized subreddits, though most users recommend keeping multiple sources open for the most complete picture.&nbsp;
RDDT Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Reddit shares ended Tuesday&#8217;s session 12.42% higher at $122.57.
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41685913/jpmorgan-to-pay-investors-151-million-after-sec-flags-various-law-violations">JPMorgan To Pay Investors $151 Million After SEC Flags &#8216;Various Law Violations&#8217;</a></li>
</ul>
Photo: Shutterstock

Social Media

RDDT

Redditors Track Election Night: Must-Watch Threads For Trump Vs. Harris Showdown, Other Races

Lake Street analyst Thomas Flaten maintained a Buy rating on Personalis (PSNL – Research Report) today and set a price target of $8.00. The company...

Lake Street Remains a Buy on Personalis (PSNL)

In a report released yesterday, Mark Massaro from BTIG maintained a Buy rating on Personalis (PSNL – Research Report), with a price target of $7.00...

Personalis (PSNL) Receives a Buy from BTIG

Personalis file to sell 3.5M shares of common stock for holders

Small-cap stocks have climbed recently. Here are the ones most poised for further upside

Small-caps get a lift after Fed's jumbo rate cut; see top 20 names per SA Quant ratings

Small-caps get a lift after Fed's jumbo rate cut; see top 20 names in SA Quant ratings

Small-caps get a lift after Fed's jumbo rate cut: See top 20 names in SA Quant ratings

Lake Street Keeps Their Buy Rating on Personalis (PSNL)

Hedge funds pile into healthcare stocks amid dip, Goldman Sachs says

The Proper Play On Personalis

AMSC

AQST

AVDV

AVUV

AXGN

BFLY

BYRN

CALF

CDNA

CLOV

COMM

CRMD

CURI

DAVE

DFAS

DFSV

ESOA

EVER

FNDA

GASS

GTHX

HMENF

HRTG

HYLN

IGIC

INSG

JAGGF

MESO

OPFI

PRAX

PSIX

RMTI

SCHA

SLNCF

SUPV

USAP

VIRC

Press Releases

Personalis to Announce Second Quarter 2024 Financial Results

Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Earnings

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Personalis Reports Second Quarter 2024 Financial Results

Personalis and Tempus Announce Expanded Collaboration

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Personalis to Participate at Upcoming Investor Conferences

ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test

Personalis to Announce Third Quarter 2024 Financial Results

Personalis to Present at the Stifel 2024 Healthcare Conference

MYGN

QGEN

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Akoya Biosciences

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

ChromaDex

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Harvard Bioscience

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

MaxCyte

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Singular Genomics Systems, Inc. - Common Stock

Singular Genomics Sys

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

HC Wainwright & Co.

BTIG

Needham

Lake Street

Morgan Stanley

테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)의 주가는 잠재적으로 암울한 분기에 대한 우려와 제품 파이프라인 계획의 전략적 변화에 대한 소문으로 인해 화요일 3일 연속 하락 마감했다. 이러한 곤경에도 불구하고 테슬라 강세를 주장하는 캐시 우드(Cathie Wood)가 운영하는 아크 인베스트(Ark Invest)는 이 주식을 매수했다.
What Happened: 아크는  ARK 이노베이션 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>), ARK 자율 기술 및 로봇 ETF (CBOE: ARKQ), ARK 차세대 인터넷 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)을 통해 325만 달러로 평가된 테슬라의 20,683 주를 매수했다. <a href="https://benzinga.grsm.io/lxquj26b2sag">벤징가 프로 데이터</a>에 따르면, 화요일 주가는 2.71% 하락한 157.11 달러에서 마감했다.
장중 주가는 최대 4.8%나 하락해 최저치인 153.75달러를 기록했고 이후 손실을 일부 만회했다.
테슬라는 현재 이 회사의 주력인 ARKK 상장지수펀드(ETF)에서 최대 비중을 보여주고, 주식 가치를 기준으로 포트폴리오의 9.83%를 차지한다. 이 펀드는 현재 6억 5,045만 달러 상당의 테슬라 주식 4,028,071주를 보유하고 있다.
참고 자료: <a href="https://www.benzinga.com/money/best-etfs">지금 매수해야 할 최고의 ETF</a>
중요성 (Why It's Important): 테슬라의 주식은 회사가 1분기 실적을 발표할 때까지 앞으로 몇 일 동안 매우 불안정할 것으로 예상된다. 테슬라는 4월 초 1분기 배송 부진을 보고한 이후로 증권사들은 이 회사의 투자 및 주가 목표치를 계속 하량 조정해 왔다.
30,000달러 미만의 EV 개발을 보류한다는 소문과 회사가 이번 주에 발표한 대규모 해고는 정서를 개선하는 데 거의 도움이 되지 않았다.
지난 금요일 이후로 주식은 약 10% 가까이 하락했으며 기술적 분석에 따르면 시장의 일반적인 혼란도 이에 힘입은 것으로 보인다. 이러한 세션 동안 회사의 시가총액은 약 560억 달러가 사라졌다.
테슬라는 화요일에 1분기 실적을 발표할 예정입니다. 벤징가 프로 데이터에 따르면 분석가들은 주당 53센트의 순이익과 226.1억 달러의 매출을 예상하고 있다. 이는 전년 동기의 주당 85센트의 순이익과 233.3억 달러에 이르는 매출과 비교된다.
다른 거래들: 
우드의 아크는 암 유전자 검사 및 분석 회사인 퍼스널리스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) 58,243주, 블레이드 에어 모빌리티(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) 78,112주를 각각 추가했다.
반면, 드래프트킹스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>)의 285,524주 와 산업 장비 대기업 캐터필러(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>)의 3,436주를 팔았다.
On Tuesday, Goldman Sachs analyst Ben Miller<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38273179/draftkings-stock-has-upside-to-street-estimates-analyst-says-sports-betting-play-wi" target="_blank" rel="noopener"> initiated coverage on DraftKings with a Buy rating with a $60 price target.</a>
화요일, 골드만 삭스의 분석가 벤 밀러(Ben Miller)는 목표 가격 60달러와 매수 등급으로 드래프트킹스에 대한 평가를 시작했다.

수요일, 캐시 우드의 아크 인베스트가 핀터레스트 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>)의 추가 주식을 구매하는 것으로 눈에 띄는 움직임을 보였다.
핀터레스트의 거래
아크 인베스트의 핀테크 이노베이션 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)는인기 소셜 미디어 웹사이트이자 메타 플랫폼이 소유한 인스타그램 및 X와 같은 플랫폼의 경쟁사인 핀터레스트의 주식 26,925주를 인수했다. 이 움직임은 핀터레스트의 금융 상황이 복합적인 가운데 이루어졌지만, 최근 <a href="https://www.benzinga.com/news/earnings/24/02/37019165/pinterest-q4-earnings-revenue-miss-eps-beat-monthly-active-users-up-11-and-more">4분기 실적</a> 보고서에서 보여준 유망한 사용자 성장을 바탕으로 한다. 이 거래의 가치는 동일 날 35.28달러의 종가를 바탕으로 하여 949,914달러이다.
아크 인베스트가 핀터레스트에 관심을 보이는 것은 이번이 처음이 아니다. 지난 2월에도 이 투자 기관은 4분기 실적에서의 혼란에도 불구하고 이 회사의 잠재력에 대한 자신감을 증명하기 위해 2,300만달러 이상의 핀터레스트 주식을 구매했다. 최근에 이루어진 이번 구매는 아크 인베스트의 핀터레스트 보유 지분을 더욱 확고히 했다.
기타 중요한 거래들:
아크 인베스트핀테크 이노베이션 ETF에서 트윌리오 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>)의 주식을 팔았다. 이 회사는 또한 게노믹 리볼루션 ETF를 위해 벌브 테라퓨틱스(Verve Therapeutics Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>)와 퍼스널리스(Personalis Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>)의 주식을 구매했다.
넥스트 제너레이션 인터넷(Next Generation Internet) ETF에서는 트윌리오의 주식을 팔고 데이터독(Datadog Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>)의 주식을 샀다.
N/A

Comments

Personalis

뉴스

에 대한 최신 뉴스 Personalis (NASDAQ:PSNL) 주식

수요일, 4월 17, 2024

목요일, 4월 04, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌